Albumin-bound Paclitaxel-based Second-line Treatment Regimens for Locally Advanced or Metastatic G/GEJ Adenocarcinoma

Clinical trial NCT07389876 · RECRUITING

Trial details

NCT number: NCT07389876
Sponsor: Fudan University
Status: RECRUITING
Study type: OBSERVATIONAL

Gastric Cancer Second-line Treatment

Start date: 2025-09-01
Primary completion: 2027-09-01
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.